Prostate cancer screening

Prior to the development of Prostate Specific Antigen, screening has been hit or miss at best. With the introduction of PSA however, scientists have been able to properly diagnose an increase of cases. Prostate Cancer Screening is designed to help answer the questions that physicians often face. A balanced set of discussions is included which provide excellent, in- depth understanding for both physician and patient understanding. Prostate Cancer Screening provides assistance for health care organizations who are struggling with the application of varying recommendations from medical specialty organizations. Armed with the information in this book, both patients and physicians will be empowered with the tools necessary to deal with the issues involved in prostate cancer screening in an informed and manner.

Wael A. Sakr and Clara WardPeter C. AlbertsenRuth Etzioni and David F. PensonIsmail JatoiFaiyaaz M. Jhaveri and Michael K. Brawer and Eric A. KleinJoseph BaslerPaul H. LangeAaron Sulman and Martin I. ResnickDavid L. ShepherdTillmann LochChris Magee and Ian M. ThompsonOtis W. BrawleyMark S. Litwin and Kristen A. ReidGregory T. SweatEvelyn C. Y. ChanZinelabidine Abouelfadel and E. David CrawfordFernand Labrie and Bernard Candas and Lionel Cusan and Jose-Luis GomezScott A. Optenberg and Atanacio C. Guillen and John P. Campbell and Ian M. ThompsonFritz H. Schroder and Ingrid van der Cruijsen-Koeter

Preface	p. v
List of Contributors	p. ix
1 Epidemiology of Prostate Cancer	p. 1
2 Natural History of Prostate Cancer	p. 25
3 Mathematical Issues: PSA Testing	p. 47
4 Evidence of Benefit of Screening in Other Cancers	p. 63
5 The Role of Prostate Specific Antigen and Its Variants in Prostate Cancer Screening	p. 79
6 The Digital Rectal Examination in Prostate Cancer Screening	p. 91
7 Philosophical Reflections on PSA Screening: What Should We Now Think and Do?	p. 97
8 Imaging in Prostate Cancer Screening	p. 105
9 Risk Factors for Prostate Cancer	p. 131
10 Transrectal Ultrasound and Artificial Neural Networks in the Diagnosis of Prostate Cancer	p. 147
11 Evidence of the Effectiveness of Prostate Cancer Screening	p. 157
12 Prostate Cancer Screening: A Note of Caution	p. 175
13 Quality of Life and Health Behavior in Prostate Cancer Screening Populations	p. 187
14 Prostate Cancer Screening Recommendations from Organized Medicine	p. 209
15 Informed Consent and Prostate Specific Antigen Screening: What Patients Ought to Know	p. 223
16 Experience of Prostate Cancer Awareness Week	p. 239
17 The Laval University Screening Trial Results	p. 255
18 Cancer of the Prostate Risk Index Test and Software (CAPRI) [CAPRI Software on Attached CD ROM]	p. 281
19 The European Randomized Study of Screening for Prostate Cancer (ERSPC)	p. 291
Index	p. 311

可借阅:*

链接这些题名

已订购

摘要

摘要

目录